Please assess the completion status of the following clinical trial:

Trial Title: Atomoxetine, Placebo and Parent Management Training in Autism

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Children 5 yrs to 14 years 11 mos with clinical diagnosis of Autism, Asperger's Disorder, or PDDNOS based upon the ADI-R and clinical evaluation by DSM-IV criteria,~* Mental age equal to or greater than 24 months,~* ADHD symptoms based upon the CASI and clinical confirmed diagnosis,~* CGIS-S rating of 4 or grater for ADHD symptoms,~* A mean item score of \>1.5 on both the Parent and Teacher (non-parent caregiver) SNAP-IV 18 ADHD symptoms or the 9-symptom hyperactive-impulsive subscale (symptoms must be cross-situational),~* Reliable care provider available to bring subject to clinic visits and weekly sessions.~Exclusion Criteria:~* DSM-IV diagnosis of schizophrenia, schizoaffective disorder psychotic disorder NOS,bipolar disorder, or major depression (if accompanied by a family history of bipolar disorder) based upon evidence of suicidality, CASI, and clinical interview/history,~* Prior failed adequate trial of atomoxetine,~* Use of other psychotropic medications that produce CNS effects,~* Diagnosis of bipolar disorder, major depression, hypertension, cardiovascular disease, narrow angle glaucoma, other significant physical illness,~* Pregnancy or sexually active females (intercourse in the past 6 months, reported by either the subject or caregiver),~* Currently on effective medication treatment for ADHD,~* Prior involvement in Parent Management Training or other similar program,~* Currently on albuterol or taking beta blockers,~* Taking supplements or other complementary medical treatments where dose cannot be held at current level for duration of study

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 14 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Atomoxetine + Parent Management Training
- 2 (Type: ACTIVE_COMPARATOR): Atomoxetine without Parent Management Training
- 3 (Type: PLACEBO_COMPARATOR): Placebo + Parent Management Training
- 4 (Type: PLACEBO_COMPARATOR): Placebo without Parent Management Training

Based on this trial design, predict the completion outcome and termination type (if applicable).